Astrocyte transcriptional machinery

Astrocyte transcriptional machinery refers to the integrated network of transcription factors, epigenetic modifiers, and co-regulators that govern the gene expression profiles of astrocytes in the central nervous system (Khakh & Deneen, 2019). This machinery is essential for maintaining astrocyte identity and executing homeostatic roles, such as neurotransmitter clearance, ion buffering, and metabolic support for neurons (Bushong et al., 2002). In response to CNS injury or disease, this machinery undergoes rapid and profound remodeling, a process known as reactive astrogliosis, which can result in either neuroprotective or neurotoxic (A1) phenotypes depending on the specific transcriptional drivers involved, such as STAT3, NF-kB, and SOX9 (Liddelow & Barres, 2017; Escartin et al., 2021). Dysregulation of these transcriptional programs is a hallmark of neurodegenerative conditions like Alzheimer's disease, Parkinson's disease, and multiple sclerosis (Zamanian et al., 2012). While not a single drug target, specific components of this machinery are being explored as therapeutic nodes to shift astrocytes from a reactive, harmful state toward a restorative one (Escartin et al., 2021).

Other names

Astrocytic gene expression systemAstrocyte-specific transcriptional regulatorsGlial transcriptional machineryAstrocyte epigenome

Modulation of astrocyte-specific gene expression programs, inhibition of pro-inflammatory reactive states (A1 phenotype), and promotion of neuroprotective or homeostatic glial functions through the targeting of specific transcription factors or epigenetic modifiers.